IS7193A - Lyfjablanda með kítósan óligómerum - Google Patents

Lyfjablanda með kítósan óligómerum

Info

Publication number
IS7193A
IS7193A IS7193A IS7193A IS7193A IS 7193 A IS7193 A IS 7193A IS 7193 A IS7193 A IS 7193A IS 7193 A IS7193 A IS 7193A IS 7193 A IS7193 A IS 7193A
Authority
IS
Iceland
Prior art keywords
oligomers
medicinal composition
treatment
compositions
chitosan oligomers
Prior art date
Application number
IS7193A
Other languages
English (en)
Other versions
IS2783B (is
Inventor
Gíslason Johannes
M. Einarsson Jon
Peter Martin
Original Assignee
Genis Ehf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genis Ehf. filed Critical Genis Ehf.
Publication of IS7193A publication Critical patent/IS7193A/is
Publication of IS2783B publication Critical patent/IS2783B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IS7193A 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður IS2783B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
PCT/IS2002/000016 WO2003026677A1 (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers

Publications (2)

Publication Number Publication Date
IS7193A true IS7193A (is) 2004-03-22
IS2783B IS2783B (is) 2012-05-15

Family

ID=36700489

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
IS7193A IS2783B (is) 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum

Country Status (13)

Country Link
US (2) US7985741B2 (is)
EP (1) EP1435976B1 (is)
JP (1) JP4613008B2 (is)
KR (1) KR20040062548A (is)
AT (1) ATE359797T1 (is)
CA (1) CA2507926C (is)
DE (1) DE60219653T2 (is)
DK (1) DK1435976T3 (is)
ES (1) ES2284935T3 (is)
IS (2) IS6085A (is)
PT (1) PT1435976E (is)
SI (1) SI1435976T1 (is)
WO (1) WO2003026677A1 (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003054208A2 (en) * 2001-12-13 2003-07-03 Ism Biopolymer Inc. Method of modulating release of saccharides and uses thereof
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
EP1670486A4 (en) * 2003-10-01 2009-04-01 Optimer Pharmaceuticals Inc TREATMENT OF A CONDITION IN A MAMMALIAN WITH ADMINISTRATION OF AMINO SUGAR AND USES THEREOF
CA2546861A1 (en) * 2003-11-24 2005-06-09 Optimer Pharmaceuticals, Inc. Treatment of a condition in a mammal with administration of compounds and methods of use thereof
EP1749532B1 (en) * 2004-05-21 2014-04-23 Tottori University Drug for remedy or treatment of wound
HUE035956T2 (en) * 2005-06-14 2018-05-28 Genis Hf Preparations of partially deacetylated chitin derivatives
US7485718B2 (en) 2005-06-16 2009-02-03 E. I. Du Pont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
WO2007001283A2 (en) * 2005-06-16 2007-01-04 E.I. Dupont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
KR100831335B1 (ko) * 2006-06-22 2008-05-22 부경대학교 산학협력단 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제
US20110212186A1 (en) * 2008-07-18 2011-09-01 Johannes Gislason Composition for treating autoimmune disorders
KR20100060634A (ko) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 미토콘드리아 활성화를 위한 조성물
KR101729137B1 (ko) * 2009-07-28 2017-04-26 (주)아모레퍼시픽 키토올리고당을 함유하는 피로회복용 조성물
MX368764B (es) 2011-06-03 2019-10-15 Maguire Abbey Llc Método, composición, y artículos para mejorar la lubricación de articulación.
CA2847569C (en) 2011-09-08 2020-05-19 Novozymes Bioag A/S Seed treatment methods and compositions comprising lipo-chitooligosaccharides
CA2848856C (en) 2011-09-14 2020-04-28 Novozymes Bioag A/S Use of lipochito-oligosaccharides and/or chito-oligosaccharides in combination with phosphate-solubilizing microorganisms to enhance plant growth
WO2013044211A1 (en) * 2011-09-23 2013-03-28 Novozymes Biologicals Holdings A/S Chitooligosaccharides and methods for use in enhancing corn growth
IN2014CN02815A (is) * 2011-09-23 2015-07-03 Novozymes Bioag As
DK2841114T3 (en) 2012-04-23 2018-09-24 Genis Hf SELF-HARDING BIOACTIVE CEMENT COMPOSITIONS WITH PARTIAL DEACETYLATED CHITIN AS BONE TRANSPLANT REPLACEMENTS
JP6285497B2 (ja) * 2016-06-07 2018-02-28 株式会社エバーライフ 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法
KR101673368B1 (ko) 2016-07-14 2016-11-08 김기혁 공정가스 반응물의 콜드트랩 장치
WO2023205718A2 (en) * 2022-04-21 2023-10-26 Hassan Ameer E Methods of treating inflammation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919122B2 (ja) * 1976-10-12 1984-05-02 味の素株式会社 水溶性部分脱アセチル化キチン及びその製造法
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JP2527317B2 (ja) * 1986-12-19 1996-08-21 ライオン株式会社 骨疾患治療剤
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
WO1998025631A1 (en) * 1996-12-13 1998-06-18 Lescarden, Inc. Treatment of osteoarthritis by administering poly-n-acetyl-d-glucosamine
JP3062592B2 (ja) * 1997-05-30 2000-07-10 農林水産省食品総合研究所長 ２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (en) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Use of chitinous materials for inhibiting cellular nitric oxide production
CA2313836C (en) * 2000-03-15 2009-06-09 Cargill, Incorporated Chitosan and method of preparing chitosan
US20020119949A1 (en) 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
HUE035956T2 (en) 2005-06-14 2018-05-28 Genis Hf Preparations of partially deacetylated chitin derivatives

Also Published As

Publication number Publication date
KR20040062548A (ko) 2004-07-07
ES2284935T3 (es) 2007-11-16
JP2005507891A (ja) 2005-03-24
WO2003026677A1 (en) 2003-04-03
DE60219653D1 (de) 2007-05-31
DE60219653T2 (de) 2008-01-03
PT1435976E (pt) 2007-06-28
IS2783B (is) 2012-05-15
US7985741B2 (en) 2011-07-26
US20050004073A1 (en) 2005-01-06
US20110257381A1 (en) 2011-10-20
DK1435976T3 (da) 2007-08-27
CA2507926C (en) 2011-12-20
EP1435976A1 (en) 2004-07-14
CA2507926A1 (en) 2003-04-03
SI1435976T1 (sl) 2007-08-31
US8415326B2 (en) 2013-04-09
EP1435976B1 (en) 2007-04-18
IS6085A (is) 2003-03-27
JP4613008B2 (ja) 2011-01-12
ATE359797T1 (de) 2007-05-15

Similar Documents

Publication Publication Date Title
IS7193A (is) Lyfjablanda með kítósan óligómerum
EP2085780A3 (en) Methods and products related to low molecular weight heparin
MX336736B (es) Composiciones de derivados de quitina parcialmente desacetilados.
WO2008015249A3 (en) Cosmetic or pharmaceutical composition containing hyaluronic acid
BRPI0711620A2 (pt) misturas poliméricas de polissacarídeos aniônicos e catiônicos e uso destas
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
TW200621745A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
ATE476450T1 (de) Vernetzte polysaccharidzusammensetzung
HK1066482A1 (en) Use os fucans in the treatment of adhesions, arthritis and psoriasis
BR0210139A (pt) Composições farmacêuticas
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
ATE441333T1 (de) Zusammensetzung enthaltend oligosaccharide als lísliche ballaststoffe zur verwendung gegen muskelschwund
JP2005507891A5 (is)
ES2161615A1 (es) Composiciones de heparinas de muy bajo peso molecular.
BRPI0418384A (pt) composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes
GB0310919D0 (en) Pharmaceutical compositions
DE602006018058D1 (de) Viskosupplementation mit algen-polysacchariden bei der behandlung von arthritis
PL375693A1 (en) Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups
SV2003001201A (es) Preparados de chitosan
NO20010940D0 (no) TAN-1057 derivater
DK1366082T3 (da) Höjsulfaterede derivater af K5-polysaccharid og deres fremstilling
ATE328603T1 (de) Modulatoren von polysacchariden und deren verwendungen
TW200510012A (en) Aqua gel comprising temperature effect
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
EP2301554A8 (en) Composition for the treatment of osteoarthritis